THE FOUNDATION FOR AIDS RESEARCH: Form 990, tax year 2015

View the entire original 990 at ProPublica ↗

Organization
THE FOUNDATION FOR AIDS RESEARCH (EIN 13-3163817)
Tax period
2015-10-01 to 2016-09-30
Filed
2017-06-20
IRS object ID
201721719349300742
Schema version
2015v3.0
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2017-06-20T15:04:19-05:00ReturnTs
Tax Period End2016-09-30TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1GRANT THORNTON LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line1757 THIRD AVE 4TH FLOORAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP100172013ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2015-10-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN133163817EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1THE FOUNDATION FOR AIDS RESEARCHBusinessNameLine1Txt
FieldValueIRS element (for citing)
In Care Of% BRADLEY JENSENInCareOfNm
Business Name ControlFOUNBusinessNameControlTxt
Phone2128061600PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1120 wall street 13TH FLOORAddressLine1Txt
CityNEW YORKCityNm
State AbbreviationNYStateAbbreviationCd
ZIP100053908ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonBRADLEY JENSENPersonNm
Person TitleASSISTANT TREAS./CFOPersonTitleTxt
Phone2128061703PhoneNum
Signature2017-06-20SignatureDt
Discuss With Paid PreparerYes (true)DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonScott ThompsettPreparerPersonNm
PTINP00741490PTIN
Phone2125990100PhoneNum
Preparation2017-06-20PreparationDt
FieldValueIRS element (for citing)
Tax2015TaxYr
Build TS2021-01-29 14:40:06ZBuildTS

Form 990 IRS990

Doing Business As Name DoingBusinessAsName

FieldValueIRS element (for citing)
Business Name Line1Aids Research Foundation or amfARBusinessNameLine1Txt
FieldValueIRS element (for citing)
Principal OfficerKEVIN FROSTPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line1120 WALL STREET 13TH FLOORAddressLine1Txt
Citynew yorkCityNm
State AbbreviationNYStateAbbreviationCd
ZIP10005ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$72,055,723GrossReceiptsAmt
Group Return For AffiliatesfalseGroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website AddressWWW.AMFAR.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1983FormationYr
Legal Domicile StateNYLegalDomicileStateCd
Activity Or Missionamfar is dedicated to ending the global AIDS EPIDEMIC THROUGH INNOVATIVE RESEARCH.ActivityOrMissionDesc
Voting Members Governing Body17VotingMembersGoverningBodyCnt
Voting Members Independent17VotingMembersIndependentCnt
Total Employee85TotalEmployeeCnt
Total Volunteers0TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$56,251,128PYContributionsGrantsAmt
CY Contributions Grants$58,810,206CYContributionsGrantsAmt
PY Program Service Revenue$0PYProgramServiceRevenueAmt
CY Program Service Revenue$0CYProgramServiceRevenueAmt
PY Investment Income$1,528,180PYInvestmentIncomeAmt
CY Investment Income$1,108,834CYInvestmentIncomeAmt
PY Other Revenue-$10,047,530PYOtherRevenueAmt
CY Other Revenue-$11,056,842CYOtherRevenueAmt
PY Total Revenue$47,731,778PYTotalRevenueAmt
CY Total Revenue$48,862,198CYTotalRevenueAmt
PY Grants And Similar Paid$9,528,182PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$10,349,259CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$10,307,568PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$10,487,770CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$739,793PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$854,723CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$5,918,761CYTotalFundraisingExpenseAmt
PY Other Expenses$17,000,831PYOtherExpensesAmt
CY Other Expenses$19,985,556CYOtherExpensesAmt
PY Total Expenses$37,576,374PYTotalExpensesAmt
CY Total Expenses$41,677,308CYTotalExpensesAmt
PY Revenues Less Expenses$10,155,404PYRevenuesLessExpensesAmt
CY Revenues Less Expenses$7,184,890CYRevenuesLessExpensesAmt
Total Assets BOY$71,251,093TotalAssetsBOYAmt
Total Assets EOY$80,773,661TotalAssetsEOYAmt
Total Liabilities BOY$18,212,471TotalLiabilitiesBOYAmt
Total Liabilities EOY$19,134,481TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$53,038,622NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$61,639,180NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionTHE FOUNDATION FOR AIDS RESEARCH IS AN INTERNATIONAL NOT-FOR-PROFIT ORGANIZATION INCORPORATED IN NEW YORK IN 1989. AMFAR WAS FORMED THROUGH THE UNIFICATION IN 1985 OF TWO NOT-FOR-PROFIT ORGANIZATIONS, THE AIDS MEDICAL FOUNDATION ("AMF"), INCORPORATED IN NEW YORK IN APRIL 1983, AND THE NATIONAL AIDS RESEARCH FOUNDATION, INCORPORATED IN CALIFORNIA IN AUGUST 1985. FIRST BASED IN CALIFORNIA, AMFAR TRANSFERRED ITS LEGAL DOMICILE TO NEW YORK IN 1989, USING THE INITIAL INCORPORATION DOCUMENTS OF AMF, MAKING IT AMF'S LEGAL SUCCESSOR. AMFAR HAS OFFICES IN NEW YORK, NY, WASHINGTON, D.C., AND BANGKOK, THAILAND. ON MARCH 7, 2005, THE BOARD OF TRUSTEES OF THE AMERICAN FOUNDATION FOR AIDS RESEARCH APPROVED A CHANGE IN LEGAL NAME TO "THE FOUNDATION FOR AIDS RESEARCH." ON OCTOBER 18, 2005, THE NEW YORK STATE DEPARTMENT OF STATE APPROVED THIS CHANGE. IN ADDITION, THE FOUNDATION HAS SECURED APPROVAL FOR DOING BUSINESS AS (DBA) THE FOLLOWING: - AMERICAN FOUNDATION FOR AIDS RESEARCH - AMFAR - AIDS RESEARCMissionDesc
Significant New Program SrvcfalseSignificantNewProgramSrvcInd
Significant ChangefalseSignificantChangeInd
Expense$20,212,802ExpenseAmt
Grant$6,558,844GrantAmt
Revenue$0RevenueAmt
DescRESEARCH: amfAR supports research projects that explore novel approaches to scientifically sound but untested hypotheses in all areas of research on HIV/AIDS, funding goal-oriented studies that often lack the preliminary data required for support from traditional grant makers. The Foundation plays a vital role in HIV/AIDS research, identifying critical gaps in knowledge and providing essential seed money that enables grantees and fellows to test the merits of new concepts or technologies that subsequently can be validated through large-scale studies, such as those funded by the U.S. National Institutes of Health. FOR FURTHER DETAILS, SEE SCHEDULE O.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$5,274,103ExpenseAmt
Grant$2,468,525GrantAmt
Revenue$0RevenueAmt
DescTREAT ASIA: amfAR's TREAT Asia (Therapeutics Research, Education, and AIDS Training in Asia) program is a network of hospitals, clinics, and research institutions working with civil society to ensure the safe and effective delivery of HIV treatments to adults and children across the Asia-Pacific through research, education, and advocacy of evidence-based HIV-related policies. The TREAT Asia Network encompasses 21 adult and 19 pediatric sites throughout the region, which collaborate on a variety of projects. FOR FURTHER DETAILS, SEE SCHEDULE O.Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Expense$3,867,810ExpenseAmt
Grant$0GrantAmt
Revenue$0RevenueAmt
DescPUBLIC INFORMATION: amfAR seeks to translate and disseminate information on important AIDS-related research, treatment, prevention, and policy issues for diverse audiences and to increase broad awareness and knowledge of the pandemic. amfAR also publishes a wide range of educational materials, maintains an informative website, and engages respected public figures, HIV/AIDS scientists, and policymakers in communicating the need for continued research to develop new methods of prevention, treatment, and, ultimately, a cure for AIDS. FOR FURTHER DETAILS, SEE SCHEDULE O.Desc

Prog Srvc Accom Acty Other ProgSrvcAccomActyOtherGrp (2 entries)

ExpenseExpenseAmtGrantGrantAmtRevenueRevenueAmtDescDesc
$2,161,783$234,816$0public policy
$1,732,068$1,087,074$0GMT Initiative
FieldValueIRS element (for citing)
Total Other Prog Srvc Expense$3,893,851TotalOtherProgSrvcExpenseAmt
Total Other Prog Srvc Grant$1,321,890TotalOtherProgSrvcGrantAmt
Total Other Prog Srvc Revenue$0TotalOtherProgSrvcRevenueAmt
Total Program Service Expenses$33,248,566TotalProgramServiceExpensesAmt
Described In Section501c3Yes (true)DescribedInSection501c3Ind
Schedule B RequiredYes (true)ScheduleBRequiredInd
Political Campaign ActyfalsePoliticalCampaignActyInd
Lobbying ActivitiesYes (true)LobbyingActivitiesInd
Subject To Proxy TaxfalseSubjectToProxyTaxInd
Donor Advised FundfalseDonorAdvisedFundInd
Conservation EasementsfalseConservationEasementsInd
Collections Of ArtYes (true)CollectionsOfArtInd
Credit CounselingfalseCreditCounselingInd
Temp Or Permanent EndowmentsYes (true)TempOrPermanentEndowmentsInd
Report Land Building EquipmentYes (true)ReportLandBuildingEquipmentInd
Report Investments Other SecfalseReportInvestmentsOtherSecInd
Report Program Related InvstfalseReportProgramRelatedInvstInd
Report Other AssetsfalseReportOtherAssetsInd
Report Other LiabilitiesYes (true)ReportOtherLiabilitiesInd
Include FIN48 FootnoteYes (true)IncludeFIN48FootnoteInd
Independent Audit Fincl StmtYes (true)IndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtfalseConsolidatedAuditFinclStmtInd
School OperatingfalseSchoolOperatingInd
Foreign OfficeYes (true)ForeignOfficeInd
Foreign ActivitiesYes (true)ForeignActivitiesInd
More Than5000 K To OrgYes (true)MoreThan5000KToOrgInd
More Than5000 K To IndividualsfalseMoreThan5000KToIndividualsInd
Professional FundraisingYes (true)ProfessionalFundraisingInd
Fundraising ActivitiesYes (true)FundraisingActivitiesInd
Gaming ActivitiesfalseGamingActivitiesInd
Operate HospitalfalseOperateHospitalInd
Grants To OrganizationsYes (true)GrantsToOrganizationsInd
Grants To IndividualsfalseGrantsToIndividualsInd
Schedule J RequiredYes (true)ScheduleJRequiredInd
Tax Exempt BondsfalseTaxExemptBondsInd
Engaged In Excess Benefit TransfalseEngagedInExcessBenefitTransInd
PY Excess Benefit TransfalsePYExcessBenefitTransInd
Loan OutstandingfalseLoanOutstandingInd
Grant To Related PersonfalseGrantToRelatedPersonInd
Business Rln With Org MemfalseBusinessRlnWithOrgMemInd
Business Rln With Fam MemfalseBusinessRlnWithFamMemInd
Business Rln With Officer EntfalseBusinessRlnWithOfficerEntInd
Deductible Non Cash ContriYes (true)DeductibleNonCashContriInd
Deductible Art ContributionfalseDeductibleArtContributionInd
Terminate OperationsfalseTerminateOperationsInd
Partial LiquidationfalsePartialLiquidationInd
Disregarded EntityfalseDisregardedEntityInd
Related EntityfalseRelatedEntityInd
Related Organization Ctrl EntfalseRelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd OrgfalseTrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted PrtshpfalseActivitiesConductedPrtshpInd
Schedule O RequiredYes (true)ScheduleORequiredInd
IRP Document128IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (true)BackupWthldComplianceInd
Employee85EmployeeCnt
Employment Tax Returns FiledYes (true)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over LimitfalseUnrelatedBusIncmOverLimitInd
Foreign Financial AccountYes (true)ForeignFinancialAccountInd
Foreign CountryTHForeignCountryCd
Prohibited Tax Shelter TransfalseProhibitedTaxShelterTransInd
Taxable Party NotificationfalseTaxablePartyNotificationInd
Nondeductible ContributionsfalseNondeductibleContributionsInd
Quid Pro Quo ContributionsYes (true)QuidProQuoContributionsInd
Quid Pro Quo Contri DisclYes (true)QuidProQuoContriDisclInd
Form8282 Property Disposed OffalseForm8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft CntrctfalseRcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft CntrctfalsePayPremiumsPrsnlBnftCntrctInd
Indoor Tanning ServicesfalseIndoorTanningServicesInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members17GoverningBodyVotingMembersCnt
Independent Voting Member17IndependentVotingMemberCnt
Family Or Business RlnfalseFamilyOrBusinessRlnInd
Delegation Of Mgmt DutiesfalseDelegationOfMgmtDutiesInd
Change To Org DocumentsfalseChangeToOrgDocumentsInd
Material Diversion Or MisusefalseMaterialDiversionOrMisuseInd
Members Or StockholdersfalseMembersOrStockholdersInd
Election Of Board MembersfalseElectionOfBoardMembersInd
Decisions Subject To ApprovafalseDecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (true)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (true)MinutesOfCommitteesInd
Officer Mailing AddressfalseOfficerMailingAddressInd
Local ChaptersfalseLocalChaptersInd
Form990 Provided To Gvrn BodyYes (true)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (true)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (true)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (true)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (true)WhistleblowerPolicyInd
Document Retention PolicyYes (true)DocumentRetentionPolicyInd
Compensation Process CEOYes (true)CompensationProcessCEOInd
Compensation Process OtherYes (true)CompensationProcessOtherInd
Investment In Joint VenturefalseInvestmentInJointVentureInd
States Where Copy Of Return Is FldALStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldAKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldARStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCOStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldFLStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldGAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldHIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldILStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldLAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMEStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNJStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNMStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldORStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldPAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldRIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldSCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldTNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldUTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldVAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWVStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWIStatesWhereCopyOfReturnIsFldCd
Own WebsiteYes (X)OwnWebsiteInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

FieldValueIRS element (for citing)
PersonBRADLEY JENSENPersonNm
Phone2128061703PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line1120 WALL STREET 13TH FLOORAddressLine1Txt
Citynew yorkCityNm
State AbbreviationNYStateAbbreviationCd
ZIP100053908ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (40 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtAverage Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtKey EmployeeKeyEmployeeIndHighest Compensated EmployeeHighestCompensatedEmployeeInd
Mathilde Krim PhD
Founding Chairman1.00.0Yes (X)Yes (X)$0$0$0
Kenneth Cole
Chairman of the Board1.00.0Yes (X)Yes (X)$0$0$0
Patricia J Matson
Vice Chairman1.00.0Yes (X)Yes (X)$0$0$0
John C Simons
Vice Chairman AND TREASURER1.00.0Yes (X)Yes (X)$0$0$0
Mervyn F Silverman MDMPH
Secretary1.00.0Yes (X)Yes (X)$0$0$0
Arlen H Andelson
Trustee1.00.0Yes (X)$0$0$0
Harry Belafonte
Trustee (NON-VOTING)1.00.0Yes (X)$0$0$0
David Bohnett
Trustee (NON-VOTING)1.00.0Yes (X)$0$0$0
Zev Braun
Trustee (NON-VOTING)1.00.0Yes (X)$0$0$0
Jonathan S Canno
Trustee1.00.0Yes (X)$0$0$0
Donald Capoccia
Trustee1.00.0Yes (X)$0$0$0
R Martin Chavez PhD
Trustee1.00.0Yes (X)$0$0$0
Jane B Eisner
Trustee (NON-VOTING)1.00.0Yes (X)$0$0$0
T Ryan Greenawalt
Trustee1.00.0Yes (X)$0$0$0
Regan Hofmann
Trustee1.00.0Yes (X)$0$0$0
Michael J Klingensmith
Trustee1.00.0Yes (X)$0$0$0
Kevin McClatchy
Trustee1.00.0Yes (X)$0$0$0
Michele V McNeill PharmD
Trustee (NON-VOTING)1.00.0Yes (X)$0$0$0
Edward Milstein
Trustee1.00.0Yes (X)$0$0$0
Cindy Rachofsky
Trustee1.00.0Yes (X)$0$0$0
Vincent A Roberti
Trustee1.00.0Yes (X)$0$0$0
Bill Roedy
Trustee1.00.0Yes (X)$0$0$0
Raymond F Schinazi PhD
Trustee1.00.0Yes (X)$0$0$0
Alan D Schwartz
Trustee (NON-VOTING)1.00.0Yes (X)$0$0$0
Diana L Taylor
Trustee (NON-VOTING)1.00.0Yes (X)$0$0$0
Kevin Wendle
Trustee (NON-VOTING)Yes (X)$0$0$0
Kevin Frost
Chief Executive Officer40.00.0Yes (X)$550,683$0$93,261
Bradley Jensen
Assistant Treasurer, CFO40.00.0Yes (X)$245,632$0$56,005
John F Logan JD PhD
AssT Sec, Vp, GEN COUNSEL40.00.0Yes (X)$228,897$0$28,695
Rowena Johnston
Asst Secretary, Vice President40.00.0Yes (X)$187,484$0$25,776
Edward Donnelly
Asst Treasurer, Controller40.00.0Yes (X)$151,164$0$22,555
Eric Muscatell
Vice President of Development40.00.0$210,876$0$27,499Yes (X)
Annette Sohn
Vice President, TREAT Asia PGM40.00.0$226,342$0$22,332Yes (X)
AnnMarie Shannahan
Vice President, Public Info.40.00.0$216,462$0$27,806Yes (X)
Gregorio Millet
Vice President, Public Policy40.00.0$180,559$0$24,932Yes (X)
Andrew McInness
Director, Publications40.00.0$154,961$0$49,713Yes (X)
Anthony Ancona
Vice President, Human Resource40.00.0$173,915$0$24,883Yes (X)
Susan Doster
Chief Technology Officer40.00.0$141,709$0$40,092Yes (X)
Bennah Serfaty
Sr Director of CommunicatiON40.00.0$123,037$0$47,434Yes (X)
JONATHAN KEY
DIRECTOR, PHILANTHROPY40.00.0$178,219$0$39,299Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$2,969,940TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$530,282TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K25IndivRcvdGreaterThan100KCnt
Former Ofcr Employees ListedfalseFormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (true)TotalCompGreaterThan150KInd
Compensation From Other SrcsfalseCompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmt
AAB PRODUCTION INC
64 ALLEN STREET 5TH FLOORNEW YORKNY10002events production$628,096
JOSH WOODS PRODUCTION
39 WEST 14TH STREET SUITE 504NEW YORKNY10011Events Production$533,000
SY YARD
25 BROADWAY 2ND FLNEW YORKNY10004MARKETING CONSULTANT$380,241
EIDOLON COMMUNICATIONS INC
15 MAIDEN LANE SUITE 1401NEW YORKNY10038DIRECT MAIL/CONSULT.$273,300
KING COMPANY
101 FIFTH AVENUE 8TH FLOORNEW YORKNY10003PUBLIC RELATIONS$208,000
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K8CntrctRcvdGreaterThan100KCnt
Federated Campaigns$267,404FederatedCampaignsAmt
Fundraising$33,932,932FundraisingAmt
Government Grants$13,063,451GovernmentGrantsAmt
All Other Contributions$11,546,419AllOtherContributionsAmt
Noncash Contributions$135,714NoncashContributionsAmt
Total Contributions$58,810,206TotalContributionsAmt
Total Program Service Revenue$0TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$1,300,886TotalRevenueColumnAmt
Exclusion$1,300,886ExclusionAmt

Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Royalties Revenue RoyaltiesRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$15,486TotalRevenueColumnAmt
Exclusion$15,486ExclusionAmt

Rental Income Or Loss RentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Real$0RealAmt
Personal$0PersonalAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$9,683,064SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$9,875,116SecuritiesAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities-$192,052SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column-$192,052TotalRevenueColumnAmt
Exclusion-$192,052ExclusionAmt
FieldValueIRS element (for citing)
Fundraising Gross Income$2,065,725FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event$33,932,932ContriRptFundraisingEventAmt
Fundraising Direct Expenses$13,267,689FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

FieldValueIRS element (for citing)
Total Revenue Column-$11,201,964TotalRevenueColumnAmt
Exclusion-$11,201,964ExclusionAmt

Net Income From Gaming NetIncomeFromGamingGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
FieldValueIRS element (for citing)
Gross Sales Of Inventory$169,839GrossSalesOfInventoryAmt
Cost Of Goods Sold$50,720CostOfGoodsSoldAmt

Net Income Or Loss NetIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$119,119TotalRevenueColumnAmt
Exclusion$119,119ExclusionAmt

Other Revenue Misc OtherRevenueMiscGrp (3 entries)

DescDescBusinessBusinessCdTotal Revenue ColumnTotalRevenueColumnAmtExclusionExclusionAmt
LIST RENTALS900099$9,117$9,117
STORE SALES900099$604$604
MISCELLANEOUS INCOME900099$796$796
FieldValueIRS element (for citing)
Other Revenue Total$10,517OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$48,862,198TotalRevenueColumnAmt
Exclusion-$9,948,008ExclusionAmt
FieldValueIRS element (for citing)
Info In Schedule O Part IXYes (X)InfoInScheduleOPartIXInd

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$5,862,816TotalAmt
Program Services$5,862,816ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$4,486,443TotalAmt
Program Services$4,486,443ProgramServicesAmt

Benefits To Members BenefitsToMembersGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$2,648,073TotalAmt
Program Services$1,927,273ProgramServicesAmt
Management And General$343,609ManagementAndGeneralAmt
Fundraising$377,191FundraisingAmt

Comp Disqual Persons CompDisqualPersonsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$5,613,504TotalAmt
Program Services$3,707,639ProgramServicesAmt
Management And General$612,539ManagementAndGeneralAmt
Fundraising$1,293,326FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$340,688TotalAmt
Program Services$223,192ProgramServicesAmt
Management And General$40,527ManagementAndGeneralAmt
Fundraising$76,969FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$1,385,492TotalAmt
Program Services$903,861ProgramServicesAmt
Management And General$202,309ManagementAndGeneralAmt
Fundraising$279,322FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$500,013TotalAmt
Program Services$324,470ProgramServicesAmt
Management And General$61,337ManagementAndGeneralAmt
Fundraising$114,206FundraisingAmt

Fees For Services Management FeesForServicesManagementGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$155,687TotalAmt
Program Services$148,384ProgramServicesAmt
Management And General$5,736ManagementAndGeneralAmt
Fundraising$1,567FundraisingAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$189,003TotalAmt
Management And General$189,003ManagementAndGeneralAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$95,320TotalAmt
Program Services$95,320ProgramServicesAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

FieldValueIRS element (for citing)
Total$854,723TotalAmt
Fundraising$854,723FundraisingAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$265,339TotalAmt
Management And General$265,339ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$1,960,502TotalAmt
Program Services$1,400,385ProgramServicesAmt
Management And General$74,386ManagementAndGeneralAmt
Fundraising$485,731FundraisingAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$258,250TotalAmt
Program Services$241,080ProgramServicesAmt
Management And General$1,621ManagementAndGeneralAmt
Fundraising$15,549FundraisingAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$76,737TotalAmt
Program Services$46,214ProgramServicesAmt
Management And General$6,340ManagementAndGeneralAmt
Fundraising$24,183FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$293,765TotalAmt
Program Services$225,841ProgramServicesAmt
Management And General$31,251ManagementAndGeneralAmt
Fundraising$36,673FundraisingAmt

Royalties RoyaltiesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$1,280,442TotalAmt
Program Services$969,575ProgramServicesAmt
Management And General$127,879ManagementAndGeneralAmt
Fundraising$182,988FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$1,191,577TotalAmt
Program Services$526,831ProgramServicesAmt
Management And General$2,892ManagementAndGeneralAmt
Fundraising$661,854FundraisingAmt

Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$732,011TotalAmt
Program Services$651,535ProgramServicesAmt
Management And General$10,086ManagementAndGeneralAmt
Fundraising$70,390FundraisingAmt

Interest InterestGrp

FieldValueIRS element (for citing)
Total$38TotalAmt
Management And General$38ManagementAndGeneralAmt

Payments To Affiliates PaymentsToAffiliatesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$462,556TotalAmt
Program Services$352,712ProgramServicesAmt
Management And General$46,520ManagementAndGeneralAmt
Fundraising$63,324FundraisingAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$315,054TotalAmt
Program Services$240,238ProgramServicesAmt
Management And General$31,685ManagementAndGeneralAmt
Fundraising$43,131FundraisingAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmtFundraisingFundraisingAmt
PROGRAM MATERIALS$8,449,443$8,449,443
POSTAGE & SHIPPING$996,058$996,058
PRINTING$815,503$236,989$407$578,107
PROGRAM TECHNICAL SUPPORT$711,501$314,466$3,164$393,871

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$1,736,770TotalAmt
Program Services$917,801ProgramServicesAmt
Management And General$453,313ManagementAndGeneralAmt
Fundraising$365,656FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$41,677,308TotalAmt
Program Services$33,248,566ProgramServicesAmt
Management And General$2,509,981ManagementAndGeneralAmt
Fundraising$5,918,761FundraisingAmt
FieldValueIRS element (for citing)
Joint CostsYes (X)JointCostsInd

Total Joint Costs TotalJointCostsGrp

FieldValueIRS element (for citing)
Total$887,518TotalAmt
Program Services$272,421ProgramServicesAmt
Fundraising$615,097FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$18,387,580BOYAmt
EOY$21,651,323EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$323,338BOYAmt
EOY$323,338EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$369,693BOYAmt
EOY$464,693EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$6,118,590BOYAmt
EOY$9,959,486EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

FieldValueIRS element (for citing)
BOY$191,382BOYAmt
EOY$575,913EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$1,480,222BOYAmt
EOY$1,630,566EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$6,869,229LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$3,892,663LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$2,288,934BOYAmt
EOY$2,976,566EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$39,666,715BOYAmt
EOY$42,064,454EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

FieldValueIRS element (for citing)
BOY$1,069,137BOYAmt
EOY$36,797EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Intangible Assets IntangibleAssetsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$1,355,502BOYAmt
EOY$1,090,525EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$71,251,093BOYAmt
EOY$80,773,661EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$3,435,700BOYAmt
EOY$3,412,592EOYAmt

Grants Payable GrantsPayableGrp

FieldValueIRS element (for citing)
BOY$3,049,552BOYAmt
EOY$2,973,966EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$10,067,061BOYAmt
EOY$10,727,662EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Escrow Account Liability EscrowAccountLiabilityGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Loans From Officers Directors LoansFromOfficersDirectorsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$1,660,158BOYAmt
EOY$2,020,261EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$18,212,471BOYAmt
EOY$19,134,481EOYAmt
FieldValueIRS element (for citing)
Organization Follows SFAS117Yes (X)OrganizationFollowsSFAS117Ind

Unrestricted Net Assets UnrestrictedNetAssetsGrp

FieldValueIRS element (for citing)
BOY$48,874,571BOYAmt
EOY$58,215,899EOYAmt

Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp

FieldValueIRS element (for citing)
BOY$3,808,811BOYAmt
EOY$3,060,748EOYAmt

Permanently Rstr Net Assets PermanentlyRstrNetAssetsGrp

FieldValueIRS element (for citing)
BOY$355,240BOYAmt
EOY$362,533EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$53,038,622BOYAmt
EOY$61,639,180EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$71,251,093BOYAmt
EOY$80,773,661EOYAmt
FieldValueIRS element (for citing)
Info In Schedule O Part XIYes (X)InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss$7,184,890ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst$1,413,485NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets$2,183OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or ReviewfalseAccountantCompileOrReviewInd
FS AuditedYes (true)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Separate Basis Fincl StmtYes (X)SeparateBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (true)AuditCommitteeInd
Federal Grant Audit RequiredYes (true)FederalGrantAuditRequiredInd
Federal Grant Audit PerformedYes (true)FederalGrantAuditPerformedInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$33,247,849CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$38,582,579CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$57,556,516CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$56,251,128CurrentTaxYearMinus1YearAmt
Current Tax Year$58,810,206CurrentTaxYearAmt
Total$244,448,278TotalAmt

Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$33,247,849CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$38,582,579CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$57,556,516CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$56,251,128CurrentTaxYearMinus1YearAmt
Current Tax Year$58,810,206CurrentTaxYearAmt
Total$244,448,278TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$6,057,646SubstantialContributorsTotAmt
Public Support Total170$238,390,632PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$897,974CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$755,293CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$804,366CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$1,652,775CurrentTaxYearMinus1YearAmt
Current Tax Year$1,316,372CurrentTaxYearAmt
Total$5,426,780TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Other Income170 OtherIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$1,624,966CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$1,467,184CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$1,693,833CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$2,103,589CurrentTaxYearMinus1YearAmt
Current Tax Year$2,246,081CurrentTaxYearAmt
Total$9,135,653TotalAmt
FieldValueIRS element (for citing)
Total Support$259,010,711TotalSupportAmt
Public Support CY1700.92039PublicSupportCY170Pct
Public Support PY1700.92323PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule C IRS990ScheduleC

FieldValueIRS element (for citing)
Total Grassroots LobbyingTotalGrassrootsLobbyingGrp
Total Direct LobbyingTotalDirectLobbyingGrp
Total Lobbying ExpendTotalLobbyingExpendGrp
Other Exempt Purpose ExpendOtherExemptPurposeExpendGrp
Total Exempt Purpose ExpendTotalExemptPurposeExpendGrp
Lobbying Nontaxable AmountLobbyingNontaxableAmountGrp
Grassroots NontaxableGrassrootsNontaxableGrp
Tot Lbbyng Grassroot Mns Non TxTotLbbyngGrassrootMnsNonTxGrp
Tot Lbby Expend Mns Lbbyng Non TxTotLbbyExpendMnsLbbyngNonTxGrp
VolunteersfalseVolunteersInd
Paid Staff Or ManagementYes (true)PaidStaffOrManagementInd
Media AdvertisementsfalseMediaAdvertisementsInd
Mailings MembersfalseMailingsMembersInd
Publications Or BroadcastfalsePublicationsOrBroadcastInd
Grants Other OrganizationsfalseGrantsOtherOrganizationsInd
Direct Contact LegislatorsfalseDirectContactLegislatorsInd
Rallies DemonstrationsfalseRalliesDemonstrationsInd
Other ActivitiesYes (true)OtherActivitiesInd
Other Activities$268,477OtherActivitiesAmt
Total Lobbying Expenditures$268,477TotalLobbyingExpendituresAmt
Not Described Section501c3falseNotDescribedSection501c3Ind
Form4720 Filed4912 TaxfalseForm4720Filed4912TaxInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceLobbying ExpensesFormAndLineReferenceDesc
ExplanationPart II-B The Foundation for AIDS Research developed an Action Agenda to End AIDS that identified critical decisions that need to be made to advance evidence based AIDS policies. We created a variety of issue briefs on topics such as the potential impact of various budget scenarios on global health services, and policy priorities to address the HIV epidemic among gay men in the US. These issue briefs were shared with Capitol Hill staff and members of the Administration. amfAR met regularly with staff to members of Congress and with Administration staff, and we provided input to the Administration on development of the PEPFAR Blueprint for an AIDS Free Generation. amfAR sponsored several briefings on Capitol Hill on AIDS policy and research issues. amfAR uses these briefings as an educational tool.ExplanationTxt

Schedule D IRS990ScheduleD

Art Public Exhibition Amounts ArtPublicExhibitionAmountsGrp

FieldValueIRS element (for citing)
Assets Included$640,959AssetsIncludedAmt
FieldValueIRS element (for citing)
Held Works ArtHeldWorksArtGrp

Collection Used Other Purposes CollectionUsedOtherPurposesGrp

FieldValueIRS element (for citing)
Collection Used Other PurposesYes (X)CollectionUsedOtherPurposesInd
Other PurposesDonated Items, Inventory etc.OtherPurposesDesc
FieldValueIRS element (for citing)
Solicited Assets SaleYes (true)SolicitedAssetsSaleInd

CY Endwmt Fund CYEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$493,036BeginningYearBalanceAmt
Contributions$7,293ContributionsAmt
Investment Earnings Or Losses$40,902InvestmentEarningsOrLossesAmt
End Year Balance$541,231EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$490,979BeginningYearBalanceAmt
Contributions$7,998ContributionsAmt
Investment Earnings Or Losses-$5,941InvestmentEarningsOrLossesAmt
End Year Balance$493,036EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$443,886BeginningYearBalanceAmt
Contributions$6,543ContributionsAmt
Investment Earnings Or Losses$40,550InvestmentEarningsOrLossesAmt
End Year Balance$490,979EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$520,804BeginningYearBalanceAmt
Contributions$3,211ContributionsAmt
Investment Earnings Or Losses$20,742InvestmentEarningsOrLossesAmt
Other Expenditures$100,871OtherExpendituresAmt
End Year Balance$443,886EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$464,356BeginningYearBalanceAmt
Contributions$4,341ContributionsAmt
Investment Earnings Or Losses$52,107InvestmentEarningsOrLossesAmt
End Year Balance$520,804EndYearBalanceAmt
FieldValueIRS element (for citing)
Prmnnt Endowment Balance EOY0.66980PrmnntEndowmentBalanceEOYPct
Term Endowment Balance EOY0.33020TermEndowmentBalanceEOYPct
Endowments Held Unrelated OrgfalseEndowmentsHeldUnrelatedOrgInd
Endowments Held Related OrgfalseEndowmentsHeldRelatedOrgInd
LandLandGrp
BuildingsBuildingsGrp

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$2,542,490OtherCostOrOtherBasisAmt
Depreciation$1,010,836DepreciationAmt
Book Value$1,531,654BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$304,196OtherCostOrOtherBasisAmt
Depreciation$288,027DepreciationAmt
Book Value$16,169BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$4,022,543OtherCostOrOtherBasisAmt
Depreciation$2,593,800DepreciationAmt
Book Value$1,428,743BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$2,976,566TotalBookValueLandBuildingsAmt
Federal Income Tax Liability$0FederalIncomeTaxLiabilityAmt

Other Liabilities Org OtherLiabilitiesOrgGrp (2 entries)

DescDescAmtAmt
LONG TERM LEASE LIABILITY$1,838,533
SECTION 457 RETIREMENT LIABILITY$181,728
FieldValueIRS element (for citing)
Total Liability$2,020,261TotalLiabilityAmt
Footnote TextYes (X)FootnoteTextInd
Total Rev Etc Audited Fincl Stmt$50,539,089TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst$1,413,485NetUnrealizedGainsInvstAmt
Donated Services And Use Fclts$261,223DonatedServicesAndUseFcltsAmt
Other Revenue$2,183OtherRevenueAmt
Revenue Not Reported$1,676,891RevenueNotReportedAmt
Revenue Subtotal$48,862,198RevenueSubtotalAmt
Total Revenue Per Form990$48,862,198TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$41,938,531TotExpnsEtcAuditedFinclStmtAmt
Donated Services Use Fclts$261,223DonatedServicesUseFcltsAmt
Expenses Not Reported$261,223ExpensesNotReportedAmt
Expenses Subtotal$41,677,308ExpensesSubtotalAmt
Total Expenses Per Form990$41,677,308TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (4 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
EndowmentsPart V, Line 4 AMFAR's endowment fund is intended to fund the various general research programs the organization sponsors.
FIN 48 - Income taxesAmfar follows guidance that clarifies the accounting for uncertainty in tax positions taken or expected to be taken in a tax return, including issues relating to financial statement recognition and guidance on measurement. This guidance provides that the tax effects from an uncertain tax position can only be recognized in the financial statements if the position is "more-likely-than-not" to be sustained if the position were to be challenged by a taxing authority. The assessment of the tax position is based solely on the technical merits of the position, without regard to the likelihood that the tax position may be challenged. Amfar has processes presently in place to ensure the maintenance of its tax-exempt status; to identify and report unrelated income; to determine its filing and tax obligations in jurisdictions for which it has nexus; and to identify and evaluate other matters that may be considered tax positions. The tax years ended SEPTEMBER 30, 2013, 2014, 2015 and 2016 are still open to audit for both federal and state purposes. amfAR has determined that there are no material uncertain tax positions that require recognition or disclosure in the financial statements.
Collections of Art, Historical Treasures, or other similar assetsPart III, Line 4 AMFAR holds various items of jewelry, photographs and other items of artistic value that have been donated to the organization for sale at special events. The organization has maintained these items in inventory for a few years and is in the process of selling them.
schedule d, part XI line 2dChange in beneficial interest $2,183

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records MaintainedYes (true)GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (10 entries)

RegionRegionTxtType Of Activities ConductedTypeOfActivitiesConductedTxtSpecific Services ProvidedSpecificServicesProvidedTxtRegion Total ExpendituresRegionTotalExpendituresAmtOfficesOfficesCntEmployeeEmployeeCnt
Central America and the CaribbeanGrantmakingN/A$25,000
East Asia and the PacificGrantmakingN/A$3,214,551
Europe (Including Iceland and Greenland)Grantmakingn/a$876,995
South AmericaGrantmakingN/A$233,783
South AsiaGrantmakingN/A$106,248
Sub-Saharan AfricaGrantmakingN/A$29,866
East Asia and the PacificProgram ServicesTHERAPEUTICS,TRAINING$1,899,975116
Europe (Including Iceland and Greenland)FundraisingN/A$10,574,889
South AmericaFundraisingN/A$803,335
South AsiaFundraisingN/A$1,998,100
FieldValueIRS element (for citing)
Subtotal Offices1SubtotalOfficesCnt
Subtotal Employees16SubtotalEmployeesCnt
Total Office1TotalOfficeCnt
Total Employee16TotalEmployeeCnt
Subtotal Spent$19,762,742SubtotalSpentAmt
Total Spent$19,762,742TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (106 entries)

RegionRegionTxtPurpose Of GrantPurposeOfGrantTxtCash GrantCashGrantAmtManner Of Cash DisbursementMannerOfCashDisbursementTxt
Central America and the CaribbeanGMT INITIATIVE$25,000wire transfe
East Asia and the PacificBASIC RESEARCH$70,860wire transfe
East Asia and the PacificBASIC RESEARCH$499,976wire transfe
East Asia and the PacificBASIC RESEARCH$169,134wire transfe
East Asia and the PacificGMT INITIATIVE$184,612wire transfe
East Asia and the PacificGMT INITIATIVE$159,255wire transfe
East Asia and the PacificGMT INITIATIVE$25,000wire transfe
East Asia and the PacificTREAT ASIA$11,648wire transfe
East Asia and the PacificTREAT ASIA$19,234wire transfe
East Asia and the PacificTREAT ASIA$5,680wire transfe
East Asia and the PacificTREAT ASIA$8,310wire transfe
East Asia and the PacificTREAT ASIA$8,100wire transfe
East Asia and the PacificTREAT ASIA$80,408wire transfe
East Asia and the PacificTREAT ASIA$5,703wire transfe
East Asia and the PacificTREAT ASIA$7,500wire transfe
East Asia and the PacificTREAT ASIA$14,997wire transfe
East Asia and the PacificTREAT ASIA$6,250wire transfe
East Asia and the PacificTREAT ASIA$19,950wire transfe
East Asia and the PacificTREAT ASIA$8,740wire transfe
East Asia and the PacificTREAT ASIA$19,748wire transfe
East Asia and the PacificTREAT ASIA$15,450wire transfe
East Asia and the PacificTREAT ASIA$15,600wire transfe
East Asia and the PacificTREAT ASIA$11,250wire transfe
East Asia and the PacificTREAT ASIA$20,656wire transfe
East Asia and the PacificTREAT ASIA$16,000wire transfe
East Asia and the PacificTREAT ASIA$15,460wire transfe
East Asia and the PacificTREAT ASIA$21,781wire transfe
East Asia and the PacificTREAT ASIA$22,604wire transfe
East Asia and the PacificTREAT ASIA$21,506wire transfe
East Asia and the PacificTREAT ASIA$24,158wire transfe
East Asia and the PacificTREAT ASIA$21,586wire transfe
East Asia and the PacificTREAT ASIA$22,338wire transfe
East Asia and the PacificTREAT ASIA$21,368wire transfe
East Asia and the PacificTREAT ASIA$14,250wire transfe
East Asia and the PacificTREAT ASIA$20,774wire transfe
East Asia and the PacificTREAT ASIA$20,224wire transfe
East Asia and the PacificTREAT ASIA$21,250wire transfe
East Asia and the PacificTREAT ASIA$5,250wire transfe
East Asia and the PacificTREAT ASIA$6,750wire transfe
East Asia and the PacificTREAT ASIA$5,925wire transfe
East Asia and the PacificTREAT ASIA$5,850wire transfe
East Asia and the PacificTREAT ASIA$5,250wire transfe
East Asia and the PacificTREAT ASIA$5,925wire transfe
East Asia and the PacificTREAT ASIA$15,000wire transfe
East Asia and the PacificTREAT ASIA$319,000wire transfe
East Asia and the PacificTREAT ASIA$166,780wire transfe
East Asia and the PacificTREAT ASIA$50,710wire transfe
East Asia and the PacificTREAT ASIA$93,567wire transfe
East Asia and the PacificTREAT ASIA$8,000wire transfe
East Asia and the PacificTREAT ASIA$183,396wire transfe
East Asia and the PacificTREAT ASIA$48,023wire transfe
East Asia and the PacificTREAT ASIA$36,345wire transfe
East Asia and the PacificTREAT ASIA$46,270wire transfe
East Asia and the PacificTREAT ASIA$7,270wire transfe
East Asia and the PacificTREAT ASIA$7,425wire transfe
East Asia and the PacificTREAT ASIA$16,537wire transfe
East Asia and the PacificTREAT ASIA$21,127wire transfe
East Asia and the PacificTREAT ASIA$14,784wire transfe
East Asia and the PacificTREAT ASIA$37,733wire transfe
East Asia and the PacificTREAT ASIA$10,814wire transfe
East Asia and the PacificTREAT ASIA$14,996wire transfe
East Asia and the PacificTREAT ASIA$12,621wire transfe
East Asia and the PacificTREAT ASIA$21,600wire transfe
East Asia and the PacificTREAT ASIA$7,021wire transfe
East Asia and the PacificTREAT ASIA$11,603wire transfe
East Asia and the PacificTREAT ASIA$7,581wire transfe
East Asia and the PacificTREAT ASIA$11,421wire transfe
East Asia and the PacificTREAT ASIA$9,023wire transfe
East Asia and the PacificTREAT ASIA$8,550wire transfe
East Asia and the PacificTREAT ASIA$24,013wire transfe
East Asia and the PacificTREAT ASIA$15,000wire transfe
East Asia and the PacificTREAT ASIA$7,992wire transfe
East Asia and the PacificTREAT ASIA$7,555wire transfe
East Asia and the PacificTREAT ASIA$35,020wire transfe
East Asia and the PacificTREAT ASIA$9,928wire transfe
East Asia and the PacificTREAT ASIA$5,625wire transfe
East Asia and the PacificTREAT ASIA$5,625wire transfe
East Asia and the PacificTREAT ASIA$5,625wire transfe
East Asia and the PacificTREAT ASIA$5,625wire transfe
East Asia and the PacificTREAT ASIA$11,250wire transfe
East Asia and the PacificTREAT ASIA$11,250wire transfe
East Asia and the PacificTREAT ASIA$11,250wire transfe
East Asia and the PacificTREAT ASIA$11,250wire transfe
East Asia and the PacificTREAT ASIA$15,000wire transfe
East Asia/PacificTREAT ASIA$15,000wire transfe
East Asia and the PacificTREAT ASIA$30,000wire transfe
East Asia and the PacificTREAT ASIA$19,142wire transfe
East Asia and the PacificTREAT ASIA$7,008wire transfe
Europe (Including Iceland and Greenland)BASIC RESEARCH$89,971wire transfe
Europe (Including Iceland and Greenland)BASIC RESEARCH$6,234wire transfe
Europe (Including Iceland and Greenland)BASIC RESEARCH$40,000wire transfe
Europe (Including Iceland and Greenland)BASIC RESEARCH$46,809wire transfe
Europe (Including Iceland and Greenland)BASIC RESEARCH$26,668wire transfe
Europe (Including Iceland and Greenland)BASIC RESEARCH$29,167wire transfe
Europe (Including Iceland and Greenland)RESEARCH$667,769wire transfe
Europe (Including Iceland and Greenland)RESEARCH$127,700wire transfe
South AmericaGMT INITIATIVE$233,783wire transfe
South AsiaGMT INITIATIVE$25,000wire transfe
South AsiaPUBLIC POLICY$30,000wire transfe
South AsiaTREAT ASIA$7,500wire transfe
South AsiaTREAT ASIA$19,104wire transfe
South AsiaTREAT ASIA$10,060wire transfe
South AsiaTREAT ASIA$6,500wire transfe
South AsiaTREAT ASIA$7,001wire transfe
South AsiaTREAT ASIA$6,583wire transfe
Sub-Saharan AfricaGMT INITIATIVE$25,000wire transfe
FieldValueIRS element (for citing)
Total501c3 Org110Total501c3OrgCnt
Transfer To Foreign CorpfalseTransferToForeignCorpInd
Interest In Foreign TrustfalseInterestInForeignTrustInd
Foreign Corp OwnershipfalseForeignCorpOwnershipInd
Passive Foreign Investmest CofalsePassiveForeignInvestmestCoInd
Foreign PartnershipfalseForeignPartnershipInd
Boycott CountriesfalseBoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Foreign ActivitiesPart I, Line 2 International organizations are recommended for funding based upon the results of community-based peer review and/or program staff assessment of proposal merit and organization capacity to undertake proposed projects that are CHARITABLE in purpose. Pre-award due-diligence for new international grantees includes review of organization documents and registrations to verify that the organization operates for a CHARITABLE purpose and that basic capacity for project oversight and governance has been established. All international grantees are required to report semi-annually on project progress and expenditures; continued reporting is required until such time as grant funds are expended in full. Reports are reviewed by administrative and program staff. Additional oversight is provided as necessary by means of ongoing, informal contact with sites regarding progress and technical issues and site visits where feasible. International research grant recipients submit an interim and a final progress reporting addition to expenditures reports due following the ends of the 2nd, 3rd and final quarters of the performance period.
foreign activitiesPart I, Line 3, Column D The Foundation for AIDS Research conducts many of its grant-making program services (see Part III of Form 990) in U.S. and foreign jurisdictions. In column D, the organization has reported the basic program these grants support; please refer to Part III for more information about these programs/initiatives.
Foreign Activities - Status of GranteesThe Foundation for Aids Research supports many non-U.S. organizations in the fight against AIDS and HIV-related diseases. For purposes of Schedule F, Part II, Line 2 - all 110 charities supported are presumed to be the equivalent of U.S. charities.

Schedule G IRS990ScheduleG

FieldValueIRS element (for citing)
Mail SolicitationsYes (X)MailSolicitationsInd
Email SolicitationsYes (X)EmailSolicitationsInd
Phone SolicitationsYes (X)PhoneSolicitationsInd
Solicitation Of Non Govt GrantsYes (X)SolicitationOfNonGovtGrantsInd
Solicitation Of Govt GrantsYes (X)SolicitationOfGovtGrantsInd
Special Fundraising EventsYes (X)SpecialFundraisingEventsInd
Agrmt Prof Fundraising ActyYes (true)AgrmtProfFundraisingActyInd

Fundraiser Activity Info FundraiserActivityInfoGrp (4 entries)

ActivityActivityTxtFundraiser Control Of FundsFundraiserControlOfFundsIndGross ReceiptsGrossReceiptsAmtRetained By ContractorRetainedByContractorAmtNet To OrganizationNetToOrganizationAmt
aab productions INC
events productionfalse$26,721,994$515,250$26,206,744
EIDOLON COMMUNICATIONS INC
direct mailfalse$2,170,244$308,509$1,861,735
Donor Services Group LLC
Tele marketingfalse$24,717$54,964-$30,247
Josh Woods Production
Special event prod.false$7,199,671$427,500$6,772,171
FieldValueIRS element (for citing)
Total Gross Receipts$36,116,626TotalGrossReceiptsAmt
Total Retained By Contractors$1,306,223TotalRetainedByContractorsAmt
Total Net To Organization$34,810,403TotalNetToOrganizationAmt
Licensed StatesALLicensedStatesCd
Licensed StatesAKLicensedStatesCd
Licensed StatesARLicensedStatesCd
Licensed StatesCALicensedStatesCd
Licensed StatesCOLicensedStatesCd
Licensed StatesCTLicensedStatesCd
Licensed StatesDCLicensedStatesCd
Licensed StatesFLLicensedStatesCd
Licensed StatesGALicensedStatesCd
Licensed StatesHILicensedStatesCd
Licensed StatesILLicensedStatesCd
Licensed StatesKSLicensedStatesCd
Licensed StatesKYLicensedStatesCd
Licensed StatesLALicensedStatesCd
Licensed StatesMELicensedStatesCd
Licensed StatesMDLicensedStatesCd
Licensed StatesMALicensedStatesCd
Licensed StatesMILicensedStatesCd
Licensed StatesMNLicensedStatesCd
Licensed StatesMSLicensedStatesCd
Licensed StatesMOLicensedStatesCd
Licensed StatesNVLicensedStatesCd
Licensed StatesNHLicensedStatesCd
Licensed StatesNJLicensedStatesCd
Licensed StatesNMLicensedStatesCd
Licensed StatesNYLicensedStatesCd
Licensed StatesNCLicensedStatesCd
Licensed StatesNDLicensedStatesCd
Licensed StatesOHLicensedStatesCd
Licensed StatesOKLicensedStatesCd
Licensed StatesORLicensedStatesCd
Licensed StatesPALicensedStatesCd
Licensed StatesRILicensedStatesCd
Licensed StatesSCLicensedStatesCd
Licensed StatesTNLicensedStatesCd
Licensed StatesTXLicensedStatesCd
Licensed StatesUTLicensedStatesCd
Licensed StatesVALicensedStatesCd
Licensed StatesWALicensedStatesCd
Licensed StatesWVLicensedStatesCd
Licensed StatesWILicensedStatesCd

Fundraising Event Information FundraisingEventInformationGrp

FieldValueIRS element (for citing)
Event1CANNESEvent1Nm
Gross Receipts Event1$15,196,962GrossReceiptsEvent1Amt
Charitable Contri Event1$14,695,962CharitableContriEvent1Amt
Gross Revenue Event1$501,000GrossRevenueEvent1Amt
Rent Facility Costs Event1$1,083,589RentFacilityCostsEvent1Amt
Food And Beverage Event1$374,402FoodAndBeverageEvent1Amt
Entertainment Event1$1,817,077EntertainmentEvent1Amt
Other Direct Expenses Event1$3,569,976OtherDirectExpensesEvent1Amt
Event2DALLASEvent2Nm
Gross Receipts Event2$5,011,152GrossReceiptsEvent2Amt
Charitable Contri Event2$4,857,027CharitableContriEvent2Amt
Gross Revenue Event2$154,125GrossRevenueEvent2Amt
Rent Facility Costs Event2$340,618RentFacilityCostsEvent2Amt
Food And Beverage Event2$177,719FoodAndBeverageEvent2Amt
Entertainment Event2$155,996EntertainmentEvent2Amt
Other Direct Expenses Event2$506,256OtherDirectExpensesEvent2Amt
Other Events Total18OtherEventsTotalCnt
Gross Receipts Other Events$15,790,543GrossReceiptsOtherEventsAmt
Charitable Contri Other Events$14,379,943CharitableContriOtherEventsAmt
Gross Revenue Other Events$1,410,600GrossRevenueOtherEventsAmt
Rent Fclty Costs Other Events$665,398RentFcltyCostsOtherEventsAmt
Food And Beverage Other Events$1,039,513FoodAndBeverageOtherEventsAmt
Entertainment Other Events$1,611,869EntertainmentOtherEventsAmt
Oth Direct Expnss Other Events$2,051,801OthDirectExpnssOtherEventsAmt
Gross Receipts Total$35,998,657GrossReceiptsTotalAmt
Charitable Contributions Tot$33,932,932CharitableContributionsTotAmt
Gross Revenue Total Events$2,065,725GrossRevenueTotalEventsAmt
Rent Fclty Costs Total Events$2,089,605RentFcltyCostsTotalEventsAmt
Food And Beverage Total Events$1,591,634FoodAndBeverageTotalEventsAmt
Entertainment Total Events$3,584,942EntertainmentTotalEventsAmt
Oth Direct Expnss Total Events$6,128,033OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events$13,394,214DirectExpenseSummaryEventsAmt
Net Income Summary-$11,328,489NetIncomeSummaryAmt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSchedule G, Part IFormAndLineReferenceDesc
ExplanationThe Foundation for AIDS Research actually paid out $854,723 in fundraising expenses for the year ending September 30, 2016. This amount is reported on Part IX, Line 11(e). For purposes of Schedule G, the Foundation is reporting all amounts paid to the consultants listed on Part I, regardless of whether such amounts were pure fundraising expenses or event production costs. On Schedule G, the total amount paid to the organizations listed is $1,306,223. Of that $1,306,223, only $854,723 was paid for fundraising services, the remaining $451,500 was paid for event production services. In the interests of clarity, the foundation would also like to make clear that the compensation reported as having been paid to the professional fundraisers reported on Schedule G is reported on a fiscal year basis. Some of those same fundraisers are reported on the foundation's top 5 highest paid independent contractors list (in Schedule O). In compliance with the instructions to the Form 990, compensation reported for Part VII (and listed in Schedule O) is reported on a calendar year basis. Accordingly, amounts on Part VII and Schedule G will not reconcile.ExplanationTxt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (true)GrantRecordsMaintainedInd

Recipient Table RecipientTable (45 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtPurpose Of GrantPurposeOfGrantTxt
Emory University
1599 Clifton RdAtlantaGA303224250580566256501(c)(3)$18,000BASIC RESEARCH
Icahn School of Medicine
One Gustave Levy PlaceNew YorkNY10029136171197501(c)(3)$30,000BASIC RESEARCH
The Rockefeller University
1230 York AvenueNew YorkNY10065131624158501(c)(3)$75,000BASIC RESEARCH
New York University
545 1st AveNew YorkNY10016135562308501(c)(3)$44,997BASIC RESEARCH
Trustees of the University of PA
422 Curie BlvdPhiladelphiaPA19104231352685501(c)(3)$50,000BASIC RESEARCH
Johns Hopkins University
733 N BroadwayBaltimoreMD21205520595110501(c)(3)$245,424GMT INITIATIVE
University of Washington
4333 Brooklyn AveSeattleWA981959472916001537501(c)(3)$90,000BASIC RESEARCH
Oregon Health & Science Uni
3181 Sam Jackson Pk RdPortlandOR97239931176109501(c)(3)$89,911BASIC RESEARCH
Emory University
1599 Clifton RdAtlantaGA303224250580566256501(c)(3)$90,000BASIC RESEARCH
Blood Systems Inc
270 Masonic AveSan FranciscoCA94118860098929501(c)(3)$90,000BASIC RESEARCH
University of Utah
15 N Medical DrSalt Lake CityUT84112876000525501(c)(3)$90,000BASIC RESEARCH
Regents of the University of CA
3333 CA St Ste 315San FranciscoCA94143946036493501(c)(3)$51,426BASIC RESEARCH
University of Nebraska-Lincoln
151 Whittier RCLincolnNE68583470049123501(c)(3)$90,000BASIC RESEARCH
Charities Aid Fdn of America
1800 Diagonal RdAlexandriaVA22314431634280501(c)(3)$224,260PREVENTION SCIENCE OUTREACH
The Rockefeller University
1230 York AveNew YorkNY10065131624158501(c)(3)$375,000BASIC RESEARCH
Johns Hopkins University
733 N BroadwayBaltimoreMD21205520595110501(c)(3)$180,869TREAT ASIA
Beth Israel Deaconess Medical Center
330 Brookline AvenueBostonMA02215042103881501(c)(3)$497,988BASIC RESEARCH
Regents of the University of CA
3333 CA St Ste 315San FranciscoCA94143946036493501(c)(3)$500,004BASIC RESEARCH
Boston Medical Center
One Boston Medical CenterBostonMA02118043314093501(c)(3)$68,750BASIC RESEARCH
Yale University
266 Whitney AveNew HavenCT06511060646973501(c)(3)$75,000BASIC RESEARCH
Fred Hutchinson Cancer Research Center
1100 Fairview Ave NSeattleWA98109237156071501(c)(3)$67,298BASIC RESEARCH
Dana-Farber Cancer Institute
44 Binney StreetBostonMA02115042263040501(c)(3)$38,737BASIC RESEARCH
University of CA San Francisco
3333 CA St Ste 315San FranciscoCA94143946036493501(c)(3)$1,778,200RESEARCH
Johns Hopkins University
733 N BroadwayBaltimoreMD21205520595110501(c)(3)$40,000PUBLIC POLICY
The George Washington University
2121 I StreetWashingtonDC20052530196584501(c)(3)$89,992BASIC RESEARCH
Harvard University
29 Oxford StreetCambridgeMA02138042103580501(c)(3)$128,438RESEARCH
New Hope for Cambodian Children
PO Box 690597KilleenTX76549205301015501(c)(3)$20,743TREAT ASIA
University of California San Diego
9500 Gilman DriveSan DiegoCA920930679956006144501(c)(3)$66,665BASIC RESEARCH
Case Western Reserve University
10900 Euclid AvenueClevelandOH44106341018992501(c)(3)$66,665BASIC RESEARCH
Case Western Reserve University
10900 Euclid AvenueClevelandOH44106341018992501(c)(3)$66,665BASIC RESEARCH
Emory University
1599 Clifton RdAtlantaGA303224250580566256501(c)(3)$66,665BASIC RESEARCH
Emory University
1599 Clifton RoadAtlantaGA303224250580566256501(c)(3)$66,665BASIC RESEARCH
Johns Hopkins University
733 N BroadwayBaltimoreMD21205520595110501(c)(3)$66,665BASIC RESEARCH
Massachusetts General Hospital
101 Huntington AveBostonMA02199042697983501(c)(3)$59,951TREAT ASIA
University of Pittsburgh
123 University PlacePittsburghPA15213250965591501(c)(3)$164,000GMT INITIATIVE
Regents of the University of CA
3333 CA St Ste 315San FranciscoCA94143946036493501(c)(3)$51,842BASIC RESEARCH
New Hope for Cambodian Children
PO Box 690597KilleeTX76549205301015501(c)(3)$50,000TREAT ASIA
Infectious Disease Research Inst
1616 Eastlake AveSeattleWA98102911608978501(c)(3)$35,000BASIC RESEARCH
University of Illinois at Chicago
809 S Marshfield AveChicagoIL60612376000511501(c)(3)$56,050BASIC RESEARCH
Regents of the University of MN
200 Oak St Ste 450MinneapolisMN55455416007513501(c)(3)$59,031RESEARCH
The Rockefeller University
1230 York AvenueNew YorkNY10065131624158501(c)(3)$20,000BASIC RESEARCH
Georgetown University
600 New Jersey AvenueWashingtonDC20057530196603501(c)(3)$99,350PUBLIC POLICY
AIDS Vaccine Advocacy Coalition
423 West 127 St 4th FlNew YorkNY10027943240841501(c)(3)$50,600PUBLIC POLICY
Project Inform
1375 Mission StreetSan FranciscoCA94103943052723501(c)(3)$10,000PUBLIC POLICY
Columbia University
630 W 168th St Box 49New YorkNY10032135598093501(c)(3)$500,000PREVENTION SCIENCE OUTREACH
FieldValueIRS element (for citing)
Total501c3 Org45Total501c3OrgCnt
Total Other Org0TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceGrants and AssistanceFormAndLineReferenceDesc
ExplanationPart I, Line 2 amfAR Provides grants and fellowships to independent not-for-profit organizations through a peer-review process. Grant applications are first reviewed by the Foundation's volunteer scientific advisory committee, which comprises recognized experts in the medical, scientific, and social sciences disciplines relevant to HIV and AIDS. The scientific advisory committee then sends its evaluations to one of the three committees (research, global initiatives or public policy) of the Foundation's program board, which serves in an advisory capacity to the Board of Trustees. After a program committee has completed its review of the applications, it presents its funding recommendations to amfAR's executive committee and/or the full Board of Trustees for final approval and funding authorization. Grants and fellowships are payable over a one-to-three-year period, and are revocable at amfAR's option if the recipient's performance or use of funds is not consistent with the terms of the grant or fellowships. In certain cases, the actual amounts paid under grants and fellowship awards may be less than the original award if the recipient does not use the full amount awarded. Therefore, a reserve for unexpended grants and fellowships has been recorded. Subawards are grants awarded to not-for-profit organizations to support the costs of collaboration and participation in HIV/AIDS-related research projects for which amfAR has secured restricted funds. Subawards are payable over a one-year period, although advance payments, in full or in part, may be issued following execution of the subaward agreement. Subawards are contingent upon the availability of funds and are revocable if the recipients' performance or use of funds is not consistent with the subaward terms.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Compensation CommitteeYes (X)CompensationCommitteeInd
Independent ConsultantYes (X)IndependentConsultantInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance PaymentfalseSeverancePaymentInd
Supplemental Nonqual Rtr PlanYes (true)SupplementalNonqualRtrPlanInd
Equity Based Comp ArrngmfalseEquityBasedCompArrngmInd
Comp Based On Revenue Of Flng OrgfalseCompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related OrgsfalseCompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng OrgfalseCompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd OrgsfalseCompBsdNetEarnsRltdOrgsInd
Any Non Fixed PaymentsfalseAnyNonFixedPaymentsInd
Initial Contract ExceptionfalseInitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (14 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
Kevin Frost
Chief Executive Officer$392,318$0$100,000$0$58,365$0$36,550$0$56,711$0$643,944$0$58,365$0
Bradley Jensen
Assistant Treasurer, CFO$245,632$0$0$0$0$0$17,401$0$38,604$0$301,637$0$0$0
John F Logan JD PhD
AssT Sec, Vp, GEN COUNSEL$228,897$0$0$0$0$0$16,120$0$12,575$0$257,592$0$0$0
Rowena Johnston
Asst Secretary, Vice President$187,484$0$0$0$0$0$13,201$0$12,575$0$213,260$0$0$0
Edward Donnelly
Asst Treasurer, Controller$151,164$0$0$0$0$0$11,019$0$11,536$0$173,719$0$0$0
Eric Muscatell
Vice President of Development$210,876$0$0$0$0$0$14,924$0$12,575$0$238,375$0$0$0
Annette Sohn
Vice President, TREAT Asia PGM$226,342$0$0$0$0$0$15,841$0$6,491$0$248,674$0$0$0
AnnMarie Shannahan
Vice President, Public Info.$216,462$0$0$0$0$0$15,231$0$12,575$0$244,268$0$0$0
Andrew McInness
Director, Publications$154,961$0$0$0$0$0$11,109$0$38,604$0$204,674$0$0$0
Anthony Ancona
Vice President, Human Resource$173,915$0$0$0$0$0$12,301$0$12,582$0$198,798$0$0$0
Susan Doster
Chief Technology Officer$141,709$0$0$0$0$0$10,338$0$29,754$0$181,801$0$0$0
Bennah Serfaty
Sr Director of CommunicatiON$123,037$0$0$0$0$0$8,830$0$38,604$0$170,471$0$0$0
Gregorio Millet
Vice President, Public Policy$180,559$0$0$0$0$0$12,852$0$12,080$0$205,491$0$0$0
JONATHAN KEY
DIRECTOR, PHILANTHROPY$178,219$0$0$0$0$0$9,545$0$29,754$0$217,518$0$0$0

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceCompensationFormAndLineReferenceDesc
ExplanationPart I, Line 4 Chief Executive Officer, Kevin Frost, participated in a supplemental nonqualified retirement plan. In calendar year 2015, Amfar contributed $60,000 into Mr. Frost's non-qualified retirement plan. This amount is not reported in Schedule J, Part II, Column (c) because the contributed amount was distributed to Mr. Frost within the same calendar year. Included in Schedule J column (b)(iii) is Mr. Frost's 2015 employer-funded 457(f) contribution of $60,000 plus payouts of previously contributed employer-funded 457(f) contributions (and earnings thereon). In Schedule J, part II, column (f), amfar is reporting $60,000 of 457(f) contributions that were recorded as deferred compensation on a previously filed Form 990.ExplanationTxt

Schedule M IRS990ScheduleM

FieldValueIRS element (for citing)
Works Of ArtWorksOfArtGrp
Art Historical TreasuresArtHistoricalTreasuresGrp
Art Fractional InterestArtFractionalInterestGrp
Books And PublicationsBooksAndPublicationsGrp
Clothing And Household GoodsClothingAndHouseholdGoodsGrp
Cars And Other VehiclesCarsAndOtherVehiclesGrp
Boats And PlanesBoatsAndPlanesGrp
Intellectual PropertyIntellectualPropertyGrp

Securities Publicly Traded SecuritiesPubliclyTradedGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
Contribution14ContributionCnt
Noncash Contributions Rpt F990$135,714NoncashContributionsRptF990Amt
Method Of Determining Revenuessales priceMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Securities Closely Held StockSecuritiesCloselyHeldStockGrp
Secur Prtnrshp Trust IntrstsSecurPrtnrshpTrustIntrstsGrp
Securities MiscellaneousSecuritiesMiscellaneousGrp
Qualified Contrib Hist StructQualifiedContribHistStructGrp
Qualified Contrib OtherQualifiedContribOtherGrp
Real Estate ResidentialRealEstateResidentialGrp
Real Estate CommercialRealEstateCommercialGrp
Real Estate OtherRealEstateOtherGrp
CollectiblesCollectiblesGrp
Food InventoryFoodInventoryGrp
Drugs And Medical SuppliesDrugsAndMedicalSuppliesGrp
TaxidermyTaxidermyGrp
Historical ArtifactsHistoricalArtifactsGrp
Scientific SpecimensScientificSpecimensGrp
Archaeological ArtifactsArchaeologicalArtifactsGrp
Any Property That Must Be HeldfalseAnyPropertyThatMustBeHeldInd
Review Process Unusual NC GiftsYes (true)ReviewProcessUnusualNCGiftsInd
Third Parties UsedfalseThirdPartiesUsedInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceForm 990, Schedule M, line 31FormAndLineReferenceDesc
ExplanationTo the extent that amFAR receives non-standard contributions, the organization's policy is to liquidate those items into cash for eventual use in support of the organization's mission.ExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (9 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Program Service Accomplishments(1)Line 4a: Research: amfAR supports research projects that explore novel approaches to scientifically sound but untested hypotheses in all areas of research on HIV/AIDS, funding goal-oriented studies that often lack the preliminary data required for support from traditional grant makers. The Foundation plays a vital role in HIV/AIDS research, identifying critical gaps in knowledge and providing essential seed money that enables grantees and fellows to test the merits of new concepts or technologies that subsequently can be validated through large-scale studies, such as those funded by the U.S. National Institutes of Health. amfAR fellowships allow talented young investigators to conduct original investigations under the guidance of experienced scientists, helping to ensure the long-term vitality of AIDS research. New Grants and Fellowships Grants Grants and fellowships are awarded through a rigorous process of peer review by a team of independent HIV/AIDS experts drawn largely from the volunteer scientists on amfAR's Scientific Advisory Committee. Guided by its scientific advisors and with the approval of its board of trustees, amfAR pursues a strategic research plan that focuses on the pursuit of a cure for HIV/AIDS. Countdown to a Cure for AIDS In 2015, amfAR announced a $100 million investment strategy to support its Countdown to a Cure for AIDS initiative, which is aimed at developing the scientific basis for a cure by 2020. The strategy represents an unprecedented expansion of amfAR's grant making and is designed to provide support to any scientist or team of investigators for any research idea with the potential to advance the search for a cure, at any stage of its development. It is structured to provide sustained support for a wide range of studies that advance both emerging and established ideas. The strategy comprises the following components: - amfAR Institute for HIV Cure Research established in 2016 with a 20 million grant over five years to the University of California, San Francisco, the Institute is the cornerstone of amfAR's cure research efforts. - Innovation Grants These two-year awards of up to $200,000 each enable researchers to test innovative ideas supported by limited preliminary data. - Impact Grants These grants of up to $2 million each over four years support the in-depth development of concepts already underpinned by preliminary data showing genuine potential for achieving a cure. - Investment Grants Aimed at recruiting the experience and expertise of scientists from outside the field of HIV, these $1 million grants are awarded over a four-year period. Grantees may have expertise in fields such as cancer, neuroscience or inflammatory disease that can directly inform efforts to cure HIV. - ARCHE Launched in 2010, the amfAR Research Consortium on HIV Eradication, or ARCHE, supports collaborative teams of scientists in the U.S. and around the world working on a range of HIV cure strategies. - Opportunity Fund This funding mechanism will enable amfAR to respond quickly to emerging and unforeseen research opportunities. In just the first 24 months of the Countdown to a Cure for AIDS initiative, amfAR has supported 139 principal investigators and key personnel in 16 U.S. states and nine other countries around the world. Innovation Grants In June, amfAR announced a new round of Innovation Grants, totaling close to $1.4 million, to allow scientists to better understand why HIV persists in the body despite effective antiretroviral therapy and pursue novel pathways to a cure. The round of grants was supported in part by the Foundation for AIDS and Immune Research (FAIR). Among the grantees is Dr. Jonathan Karn of Case Western Reserve University in Cleveland, Ohio, who is aiming to develop a more accurate, cost - and time-efficient way to measure the size of the viral reservoir, which is essential for gauging the effectiveness of potentially curative interventions. Karns method could reduce the need for burdensome blood draws and greatly increase the number of patients who can be tested at one time. Another grantee, Dr. Maud Mavigner of Emory University in Atlanta, is conducting a comprehensive study to identify the most accurate methods to measure the viral reservoir in rhesus macaques infected with SIV, the non-human primate equivalent of HIV. SIV-infected rhesus macaques have helped answer some of the most crucial questions in HIV research. And a third grantee, Dr. Celsa Spina of the University of California, San Diego, is studying how and where HIV inserts itself into our DNA, enabling it to establish the hidden viral reservoir. The particular region can help determine whether the virus actively replicates or remains latent. The results of Spinas research will be important as we develop new drugs to target this reservoir. Investment grants In January 2016, amfAR awarded $1 million each over four years to Harvard physicist Dr. David Weitz and bioengineer and polymer scientist Dr. Alexander Zelikin of Aarhus University in Denmark. The two will collaborate with leading HIV researchers Drs. Bruce Walker and Martin Tolstrup at Harvard and Aarhus, respectively, in the effort to eradicate the viral reservoir, which is considered the principal barrier to curing HIV. Weitz proposes to isolate the most effective T cells from those that are less potent, clone them in a petri dish, and use a mouse model to test whether the reinjection of these killer cells can lead to a functional cure for HIV. An expert in prodrugs, Zelikin will design a two-component cocktail - one will gently reawaken the latent HIV and the second will specifically initiate the killing of virally infected cells. ARCHE (amfAR Research Consortium on HIV Eradication) In October 2015, amfAR provided $850,000 of renewal ARCHE funding to a consortium of European researchers who aim to replicate the case of the "Berlin patient," the first and only person known to have been cured of HIV. Diagnosed with leukemia, the patient was given a stem cell transplant with a twist: the cells he received were taken from a donor with a rare genetic mutation conferring resistance to HIV infection. Led by Dr. Javier Martinez-Picado of IrsiCaixa in Spain and Dr. Annemarie Wensing of University Medical Center Utrecht in the Netherlands, the team has already identified a group of patients who have undergone transplants and continues to monitor their progress in the hopes of generating new knowledge that can inform more widely applicable interventions. amfAR also awarded a $672,000 ARCHE grant in June to support a research team led by Dr. Timothy Schacker of the University of Minnesota, Minneapolis. Schacker is collaborating with a pair of leading investigators from the amfAR Institute for HIV Cure Research, Drs. Steven Deeks and Peter Hunt of the University of California, San Francisco (UCSF), to address one of the greatest challenges in HIV cure research: how to establish whether a person has been cured. Mathilde Krim Fellowships In October 2015, amfAR awarded a total of $600,000 in Mathilde Krim Fellowships in Basic Biomedical Research, an annual initiative that provides funding for exceptional young researchers who are new to the field of HIV/AIDS research. The program, which was created in 2008 in honor of amfARs founding chairman, has achieved spectacular results, including numerous published studies in major scientific journals. Each Krim Fellow receives $150,000 in funding over two years. Dr. Luis Agosto of Boston Medical Center is exploring one of the mechanisms that perpetuates the viral reservoir, with the goal of understanding how the virus evades the immune system. Dr. Liang Shan of Yale University in New Haven, CT, is using a humanized mouse model to test the efficacy of latency reversing drugs, studying their ability to reactivate HIV so that the immune system can kill those cells that harbor the virus. Dr. Louise Scharf of the California Institute of Technology in Pasadena is studying the molecular structure of broadly neutralizing antibodies isolated from two HIV-infected patients to better understand how these powerful antibodies can help in the development of a vaccine against the virus. And Dr. Amit Sharma of the Fred Hutchinson Cancer Research Center in Seattle, WA, is investigating how rhesus macaques can be better utilized as an animal model in HIV vaccine studies. Published Research Research studies make the greatest impact on the AIDS field and on the broader scientific community when they are published in scientific journals. In FY2016, 64 scientific publications resulted from amfAR-funded research. Examples include: Harnessing the Power of Antibodies Writing in the May issue of the journal Science, amfAR Krim Fellow Dr. Stylianos Bournazos and associates reported using a single broadly neutralizing anti-HIV antibody to target infected CD4 T cells in mice with a humanized immune system (i.e., mice that have been injected with human stem cells). Working i
Program Service Accomplishments (2)Line 4b: TREAT ASIA: amfAR's TREAT Asia (Therapeutics Research, Education, and AIDS Training in Asia) program is a network of hospitals, clinics, and research institutions working with civil society to ensure the safe and effective delivery of HIV treatments to adults and children across the Asia-Pacific through research, education, and advocacy of evidence-based HIV-related policies. The TREAT Asia Network encompasses 21 adult and 19 pediatric sites throughout the region, which collaborate on a variety of projects. TREAT Asia scientists produced a record 34 publications in peer-reviewed medical journals in 2016. In 2016, amfAR successfully re-competed for funding for a new five-year cycle (2016-2021) that will be supported by the National Institute of Allergy and Infectious Diseases (NIAID), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the National Cancer Institute (NCI), and for the first time the National Institute of Mental Health (NIMH) and the National Institute on Drug Abuse (NIDA). The renewal application includes multiple studies that will be conducted across 58 institutions in 13 countries. The studies will help the program address emerging and critical issues facing people living with HIV who are transitioning from pediatric to adolescent care, and aging into older adults. TREAT Asia HIV Observational Database (TAHOD) TREAT Asia pioneered the region's first adult observational database for HIV/AIDS, which now includes anonymous data collected from approximately 9,000 patients at 20 clinical sites in 12 countries. The information gathered and analyzed through the database informs the development of more effective research and treatment programs, and helps define treatment standards specific to HIV/AIDS in Asia. International AIDS Database TREAT Asia manages the Asia-Pacific section of the International Epidemiologic Databases to Evaluate AIDS (IeDEA), a global collaboration established by the U.S. National Institute of Allergy and Infectious Diseases. In FY2016, the IeDEA consortium funded the second year of a study aiming to measure and better understand treatment adherence among young people with HIV. The study, which was conducted at the three participating IeDEA sites in Kenya, South Africa, and Thailand, evaluated factors that increase the risk of non-adherence and assessed the impact on treatment failure and clinic dropout. TREAT Asia Pediatric Network TREAT Asia's Pediatric Network includes 19 sites in six countries; these sites share information and best practices in an effort to improve the quality of pediatric care in the region. The TREAT Asia Pediatric HIV Observational Database (TApHOD) was modeled on the adult database and includes data from approximately 6,000 pediatric patients in Cambodia, India, Indonesia, Malaysia, Thailand, and Vietnam. TREAT Asia has been following a prospective cohort of 248 HIV-infected adolescents to evaluate multiple social, cultural, and behavioral factors that affect treatment adherence using an audio computer-assisted self-interview (ACASI) instrument at nine TApHOD sites in Malaysia, Thailand, and Vietnam. Among the study findings so far are that adolescents with effective virologic suppression are less likely to report high-risk sexual behaviors, such as inconsistent condom use. This emphasizes the need to promote and support strategies to achieve viral suppression as a key priority for adolescents who are struggling to adhere to antiretroviral therapy. This study was supported by the AIDS Life Foundation. Additional Adolescent Research In 2016, amfAR was awarded a Developmental Research Grant by the National Institutes of Health to improve how data on adolescents living with HIV are collected in resource-limited settings. The co-Principal Investigators- Treat Asia Director Dr. Annette Sohn and Dr. Mary-Ann Davies of the University of Cape Town, South Africa - are leading a team to establish a data collection and management platform that can guide clinical programs as to the socio-economic, clinical, and laboratory data needed to characterize how adolescents with HIV are transitioning to adult HIV care. The initiative, called GRADUATE: a Global fRAmework of Data collection Used for Adolescent HIV Transition Evaluation, will be implemented in Malawi, South Africa, and Thailand over the next two years. Expanding Pre-Exposure Prophylaxis (PrEP) for Female Sex Workers in Thailand In 2016, amfAR funded a study to assess combination HIV prevention needs, including pre-exposure prophylaxis (PrEP), among female sex workers in Bangkok and Pattaya, Thailand. The research team brings together experts from the Service Workers in Group (SWING) Foundation, a Thai advocacy organization for sex workers; Institute for Population and Social Research at Mahidol University in Bangkok; Johns Hopkins Bloomberg School of Public Health in Baltimore, MD; and amfAR. The researchers have collected data using focus groups, key informant interviews, and a questionnaire among 180 female sex workers to examine PrEP knowledge and acceptability and to document behavioral, social, and structural factors known to place women at risk for HIV. Addressing Unmet Needs in HIV Care In January 2016, TREAT Asia embarked on a think tank project to identify and address gaps in the management of HIV in Asia. The project is bringing together over 20 experts in HIV and other sub-specialties from Australia, China and Hong Kong SAR, India, Indonesia, the Philippines, South Korea, Taiwan, Thailand, Cambodia, Japan, Malaysia, and Vietnam. The think tanks are focusing on three priority areas: HIV and cardiovascular disease, HIV and liver disease, and HIV and drug resistance. Building Community Treatment Literacy and Promoting Advocacy for Treatment Access TREAT Asia works closely with regional organizations to support treatment literacy activities, including the production of "community-friendly" educational brochures on HIV treatment standards in local languages. In February and May 2016, TREAT Asia held two Youth ACATA (Asia Community for AIDS Treatment and Advocacy) workshops in Bangkok for young people living with HIV from Cambodia, Indonesia, and Thailand. In 2013, approximately 190,000 children and adolescents were living with HIV in the region. Launched in 2015 with support from ViiV Healthcares Positive Action for Adolescents program, Youth ACATA aims to educate participants about HIV and antiretroviral therapy and connects them to other HIV-positive youth in the region. In December 2015, Adams Love, the online HIV outreach initiative targeting gay men, other men who have sex with men (MSM), and transgender individuals (collectively, GMT) cut the ribbon on its new clinic in the heart of Bangkok. The clinic, established with support from amfAR, aims to appeal to discreet, harder-to-reach GMT individuals who might be hesitant to visit public government clinics for HIV testing and care. Part of an amfAR Implementation Science study, it will test three innovative HIV outreach and care models- each targeting a different subset of the GMT population. In addition, TREAT Asia continued to publish lay-language articles on AIDS research, policy, and community issues facing the TREAT Asia network and the Asia-Pacific as a whole. The articles and educational pieces appear in the TREAT Asia Report, a bimonthly e-newsletter, and on TREAT Asias website, www.treatasia.org. Treating HIV and Hepatitis C Co-Infection In May, TREAT Asia co-sponsored a one-and-a-half-day training in Bangkok for clinicians on treating hepatitis C and HIV co-infection with direct-acting antivirals (DAAs). More than 30 primary care and infectious disease physicians, patients, and treatment access advocates from six countries in South and Southeast Asia attended. The agenda included understanding steps for diagnosing hepatitis C infection, managing treatment side effects, and reviewing clinical care and treatment responses among people who inject drugs. TREAT Asia conducted the training in collaboration with the International Network for Hepatitis in Substance Users (INHSU) and the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM). Expanded Access to Hepitatis C Treatments In August, TREAT Asia hosted its fourth regional strategic meeting on hepatitis C virus treatment access in Bangkok, with 22 participants from Cambodia, China, Indonesia, India, Malaysia, Nepal, Thailand, and Vietnam. The meeting included representatives from key population regional networks, including Mdecins Sans Frontires (MSF) Access Campaign, the Drugs for Neglected Diseases Initiative (DNDi), and the Lawyers Collective (a public interest service provider in India). Participants agreed to work with national partners to increase access to direct-acting antivirals by reducing regulatory barriers and ensuring affordable pricing. 15th Annual Network Meeting The 2015 TREAT Asia Annual Network Meeting was held Oct
Program Service Accomplishments (3)Line 4c: PUBLIC INFORMATION: amfAR seeks to translate and disseminate information on important AIDS-related research, treatment, prevention, and policy issues for diverse audiences and to increase broad awareness and knowledge of the pandemic. amfAR also publishes a wide range of educational materials, maintains an informative website, and engages respected public figures, HIV/AIDS scientists, and policymakers in communicating the need for continued research to develop new methods of prevention, treatment, and, ultimately, a cure for AIDS. Educational Materials amfAR produces a range of periodicals in both print and electronic formats, including its newsletter Innovations, published twice a year and distributed to more than 45,000 people; the TREAT Asia Report, an e-mail newsletter distributed six times a year to more than 4,000 readers in the international health community; and a monthly e-mail newsletter distributed to nearly 100,000 people. The Foundation's website features news, interviews, blog posts, and original articles covering AIDS research, policy, the global epidemic, and amfAR programs and activiites. The website attracts an average of 40,000 visitors per month. amfAR also creates and distributes program reports, press releases, and updates on major HIV/AIDS issues and conducts public service advertising campaigns that have been instrumental in educating policymakers, healthcare professionals, people living with HIV/AIDS, and the general public. Social Media amfAR vigorously expanded its presence in the social media arena, reaching large numbers of people, including a younger demographic that is often less educated about HIV and the AIDS epidemic. The Foundation regularly adds content to its Facebook page, live tweets from events, and posts images on Instagram from fundraising and program events. amfAR has 72,000 likes on Facebook, 40,000 Twitter followers, and more than 108,000 Instagram followers. Media Outreach amfAR continued to work closely with the media to raise the profile of HIV/AIDS, both domestically and internationally, and to help ensure the accuracy of AIDS-related press coverage. Articles and reports involving amfAR-many of which included interviews with amfAR staff and spokespeople-were carried in numerous media outlets, including the New York Times, Forbes, The Advocate, CBS Radio, Reuters, Bloomberg News, and the South China Morning Post. Celebrity Support amfAR's public awareness efforts are greatly enhanced by the committed support of public figures who lend their voices and donate their time, talents, and resources to help sustain the Foundation's mission. Support of amfAR by prominent public figures began with the late Dame Elizabeth Taylor, amfAR's Founding International Chairman, and others have followed in her footsteps. amfAR is profoundly grateful for the continuing steadfast support of Global Campaign Chair Sharon Stone. In 2016, a collection of 1980s classic hits was updated by contemporary artists for The Time is Now!, a 14-track compilation album to benefit amfAR. The album features a soulful rendition of Michael Jacksons "Billie Jean" by singer-songwriter Aloe Blacc and a rendition of New Order's "Bizarre Love Triangle" performed by Sugar for Sugar, consisting of Scarlett Johansson, Julia Haltigan Holly Miranda, and Kendra Morris. The band Lower Dens, pop rock group DNCE, Dita Von Teese and Sebastien Tellier, and songwriting duo Marian Hill are also featured on the album. Other celebrity supporters included amfAR Ambassadors Milla Jovovich, Michelle Yeoh, and Cheyenne Jackson, Kathy Bates, Angela Bassett, Julia Roberts, Matt Bomer, Jamie Lee Curtis, Diane von Furstenberg, Gwyneth Paltrow, Chiara Ferragni, Ryan Murphy, Kevin Spacey, Lady Gaga, Diane Kruger, Uma Thurman, Dame Helen Mirren, Faye Dunaway, Katy Perry, Kate Moss, Marc Jacobs, Ricky Martin, amfAR Trustee Jay Ellis, Lea Michele, Michelle Rodriguez, Whoopi Goldberg, amfAR Trustee Harry Belafonte, Naomi Campbell, Heidi Klum, Riccardo Tisci, Adrien Brody, Eva Longoria, Harvey Keitel, Harvey Weinstein, Leonardo DiCaprio, Robert De Niro, Robin Thicke, Andrea Bocelli, Dean and Dan Caten, Chris Tucker, Jennifer Garner, Donatella Versace, and Carine Roitfeld.
Program Service Accomplishments (4)Line 4d: THE GMT INITIATIVE: Since 2007, amfAR has been serving the HIV-related needs of gay men, other men who have sex with men (MSM), and transgender individuals (collectively, GMT) throughout the developing world through its GMT Initiative. Through small, targeted grants to grassroots groups, amfAR has expanded access to HIV education and prevention services; supported advocacy aimed at increasing funding for prevention and treatment services; and worked to end the stigma, discrimination, and violence that threaten the lives of GMT and fuel the spread of HIV/AIDS. In September 2015, amfAR awarded an 18-month grant to the Kirby Institute at the University of New South Wales in Sydney, Australia, to extend the Opposites Attract Study underway in Brazil and Thailand. The study is being led by Dr. Andrew E. Grulich of The Kirby Institute and is evaluating the role of combination antiretroviral therapy as a "treatment of prevention" strategy among serodiscordant male homosexual couples in Australia, Brazil, and Thailand. The same funding was used to support clinics at the Instituto de Pesquisa Clnica Evandro Chagas (IPEC) in Rio de Janeiro and the Thai Red Cross AIDS Research Centre in Bangkok, which have been participating in the study since May 2014. Implementation Science Awards In FY2016, amfARs grant making through the GMT Initiative evolved to support larger implementation science projects aimed at identifying barriers to HIV testing, treatment, and care and studying the impact of innovative HIV service delivery models for GMT in low- and middle-income countries. amfAR has awarded $2.6 million over three years to support three such studies. Dr. Chris Beyrer of Johns Hopkins University is leading a team of researchers and community-based services (in collaboration with the International HIV/AIDS Alliance Myanmar) in evaluating the effectiveness of promising interventions for GMT in Myanmar, where increased HIV testing and treatment opportunities are becoming available. The researchers are assessing the effectiveness of HIV self-testing done in the privacy of ones home, point-of-care CD4 testing, and the use of "peer navigators" familiar with the local health system to help those newly diagnosed gain access to HIV treatment and care. In Lima, Peru, Dr. Javier Lama of Asociacin Civil Impacta Salud y Educacin and his team are aiming to improve the continuum of care among transgender women by using an innovative model that integrates HIV prevention and treatment services with transgender-affirming medical care. Working in collaboration with the Boston-based Fenway Institute and two community GMT organizations, IMPACTA and EPICENTRO, Dr. Lama and his team are integrating routine cross-sex hormone therapy into HIV and sexually transmitted infection prevention, testing, and treatment services and implementing health services and peer case management for 200 transgender women. And in Bangkok, Thailand, Dr. Nittaya Phanuphak and her team at the Thai Red Cross AIDS Research Centre are working to show how innovative technologies such as GMT-targeted websites using online counseling and support can be utilized to increase rates of HIV testing and referrals to prevention and treatment programs. Working in collaboration with Adams Love, a web-based health platform for GMT individuals, and two community-based organizations (Service Workers in Group/SWING and The Rainbow Sky Association of Thailand), the team are comparing the effectiveness of online services and support interventions with traditional clinic-based HIV services, and a hybrid model that combines elements of both strategies. amfAR HIV Scholars Program In FY2016, amfAR supported four young researchers from Paraguay, Brazil, South Africa, and Indonesia undergoing five months of graduate-level public health study at the Center for LGBT Health Research of the Graduate School of Public Health at the University of Pittsburgh as part of the amfAR HIV Scholars Program. The program aims to strengthen GMT community-based research and responses to HIV, often in areas where little data about HIV among GMT currently exist and where stigma and discrimination deter many from seeking HIV testing and services. The 2016 amfAR HIV Scholars are Dr. Antonio Spagnolo of the National University of Asuncin in Paraguay; Daniel Dutra de Barros of Santa Casa de So Paulo School of Medical Sciences in Brazil; Kabelo Maleke of Project Boithato at the Anova Health Institute in rural South Africa; and Adi Nugroho of the GWL-INA Network in Jakarta, Indonesia. Publications As part of its efforts to raise awareness among governments, donors, and international nongovernmental organizations about the spread of HIV among GMT individuals and to advocate for effective strategies to address it, amfAR publishes a range of reports on HIV and GMT. In November 2015, amfAR - along with the International AIDS Vaccine Initiative (IVAI), the Johns Hopkins University- Center for Public Health and Human Rights (JHU-CPHHR), and the United Nations Development Program (UNDP)- released updated guidelines to Respect, Protect, Fulfill, a document that offers practical advice on how to engage gay men and other MSM in epidemiologic and intervention research, including HIV prevention and treatment trials. First released in 2011, the guidance helps researchers and community-based organizations maximize the benefits and minimize any potential risks of working together on critically needed research involving this population. The revised Respect, Protect, Fulfill was compiled through a participatory process that enlisted input from researchers and community leaders and organizations throughout the world.
Program Service Accomplishments (5)Line 4d: public policy: Informed by thorough research and analysis, amfAR is a highly respected advocate of rational and compassionate AIDS-related public policy. The Foundation is engaged in efforts to secure necessary increases in funding for HIV/AIDS research; implement the U.S. National HIV/AIDS Strategy; expand access to care and treatment; and protect the civil rights of all people affected by HIV/AIDS. Shaping the Domestic Response to HIV/AIDS amfAR has long advocated the implementation of a comprehensive national HIV/AIDS strategy to address the epidemic in the U.S., where more than 1.2 million people are living with the virus. In February 2016, amfAR published an infographic titled, Small Increase, Big Impact, illustrating the declining purchasing power of the National Institutes of Healths (NIH) HIV/AIDS research dollars. In 2016, the NIH budget was increased by $2 billion, and President Obama proposed a further increase of $825 million for 2017. However, HIV research funding remained at 2015 levels. An increase in HIV research funding in line with the increase in total NIH funding would have meant an additional $76.6 million for HIV research for 2017. Such an increase would have allowed the NIH to fund 180 HIV/AIDS studies that could significantly advance HIV prevention, treatment or cure research; fund 51 clinical trials focused on curing HIV; or fund a breakthrough prevention trial. Key Populations amfAR is dedicated to addressing the needs of the people most vulnerable to HIV infection: men who have sex with men, sex workers, people who inject drugs, and transgender people. In October 2015, amfAR published Towards Defining an HIV Implementation Science Agenda for Key Populations in Low- and Middle-Income Countries based on a meeting the Foundation hosted in May 2015 to brainstorm how implementation science research might improve HIV outcomes for key populations in resource-limited settings. While significant progress has been made in the fight against AIDS, there remains a considerable gap between the potential of existing prevention and treatment tools and their actual impact on people affected by the virus. amfAR published Following the Money to Key Populations, National Priorities, and Evidence-Based Budgeting in June, a qualitative assessment of how Kenya and South Africa use health data for budgetary resource allocation. The Foundation, along with the Centre for Economic Governance and AIDS in Africa (CEGAA) and AVAC, reviewed resource allocation for health and HIV interventions, identified epidemiological data currently in use, highlighted information and procedural gaps in resource allocation for key populations, and developed recommendations for future research. In July, amfAR published the report Is PEPFAR Funding for Key Populations Aligned with the Epidemiologic Burden? based on an evaluation of the U.S. Presidents Emergency Plan for AIDS Relief (PEPFAR). Worldwide, 40-50% of all HIV infections in adults aged 15-49 occur among key populations. The report concluded that the disproportionate HIV risk along with poor quality health services underscore the continuing importance of prioritizing resources and targeted interventions. Global Health In FY2016, amfAR published The World Without PEPFAR, an infographic highlighting significant advances in global HIV/AIDS treatment and prevention made possible by the U.S. Presidents Emergency Plan for AIDS Relief (PEPFAR). Launched in 2003, PEPFAR made billions of dollars available for HIV programs in developing countries and fundamentally changed the course of the global epidemic. amfAR also added new features and data to its PEPFAR Country/Regional Operational Plan database, a comprehensive, navigable database of PEPFARs planned funding of HIV/AIDS activities from 2007 to 2015. Launched in 2015, the database is designed to help civil society organizations, ministries of health and finance, researchers, and other stakeholders access and understand PEPFARs programs and priorities on a deeper level than was possible using other platforms.
Policiesform 990, part vi, section b Line 11 - The Form 990 was prepared by a nationally renowned accounting firm in conjunction with the organization's financial department. A copy of the draft Form 990 was circulated to the full Board of Trustees for discussion and comment. Each Board Member was provided ample opportunity to comment on the information contained in the 990 prior to its filing with the Internal Revenue Service. Line 12 - Each officer, director, trustee and key employee of amFar ("foundation") is required to annually disclose any conflicts of interest that arise by virtue of employment, board service, or position with the foundation. The foundation monitors compliance with its conflict of interest policy through an annual questionnaire/disclosure statement that is distributed to these individuals. Potential conflicts are investigated immediately. LINE 15 - AMFAR ("FOUNDATION FOR AIDS RESEARCH") UNDERTAKES A THOROUGH PROCESS TO ENSURE THAT THE COMPENSATION IT PAYS TO ITS TOP MANAGEMENT OFFICIAL AND ALL OF ITS OFFICERS AND KEY EMPLOYEES IS REASONABLE GIVEN THE MARKET IN WHICH THE FOUNDATION OPERATES. AN INDEPENDENT CONSULTING FIRM QUALIFIED IN THE AREA OF NONPROFIT COMPENSATION PREPARES AN ANALYSIS OF MARKET COMPENSATION RANGES BY JOB FUNCTION AND PRESENTS IT TO THE COMPENSATION COMMITTEE OF THE BOARD. ON THE BASIS OF THIS INFORMATION, STAFF COMPENSATION IS DETERMINED ACCORDING TO SALARY RANGES APPROVED BY THE COMPENSATION COMMITTEE OF THE BOARD, IN CONSULTATION WITH THE CEO AND CFO. CEO COMPENSATION IS REVIEWED AND DETERMINED BY THE COMPENSATION COMMITTEE OF THE BOARD UTILIZING THE INDEPENDENT CONSULTANT ANALYSIS.
DisclosureForm 990, Part VI, Section C LIne 19 - amfar makes its Form 990 available to the public by retaining a copy at its place of business and on its website, www.amfar.org. The Form 990 is likewise published on the internet at www.guidestar.org. The Foundation's financial statements are made available in its annual report and on its website. The Foundation's governing documents and conflict of interest policy are not ordinarily made available to the public, but, if requested, will be provided at management's discretion.
Functional ExpensesPart IX, Lines 1 & 3 The Foundation for AIDS Research reports its grants net of grant returns or recoveries. Periodically, grants remitted to charitable organizations are returned to AMFAR for a variety of reason. On Schedules F & I, grants are reported irrespective of whether they were ultimately returned to AMFAR since categorizing the "returned" amounts would be time consuming. Therefore, amounts reported on Part IX, Line 1 will not tie to total grants on Schedule I; amounts reported on Part IX, Line 3 will not tie to total grants on Schedule F.
OTHER CHANGES IN NET ASSETSFORM 990, SECTION XI, LINE 9 CHANGE IN VALUE OF THIRD PARTY TRUST......... $2,183 ------- TOTAL LINE 9 $2,183

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.